Dunedin, New Zealand

Mark Dalphin

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 12(Granted Patents)


Location History:

  • Maori Hill, NZ (2018)
  • Dunedin, NZ (2018 - 2021)

Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mark Dalphin: Innovator in Bladder Cancer Detection

Introduction

Mark Dalphin is a notable inventor based in Dunedin, New Zealand. He has made significant contributions to the field of medical diagnostics, particularly in the detection and treatment of bladder cancer and related conditions. With a total of three patents to his name, Dalphin's work is paving the way for improved patient outcomes.

Latest Patents

Dalphin's latest patents include innovative methods for the detection of markers associated with bladder cancer and inflammatory conditions of the bladder. One of his key inventions focuses on the detection of genetic markers that can indicate the presence of bladder cancer. This method enhances the accuracy of diagnosis and provides better detection capabilities for inflammatory conditions of the bladder. Another significant patent introduces the G+P INDEX, a new metric that combines phenotypic variables and genotypic expression to assess the risk of urothelial carcinoma in patients with hematuria. This approach allows for more efficient clinical decision-making, potentially saving time and resources by avoiding unnecessary diagnostic procedures for patients deemed to be at low risk.

Career Highlights

Dalphin's career is marked by his dedication to advancing medical technology and improving patient care. His work at Pacific Edge Limited has positioned him as a leader in the field of bladder cancer diagnostics. His innovative approaches have garnered attention and recognition within the medical community.

Collaborations

Dalphin collaborates with talented professionals such as Laimonis Kavalieris and Paul O'Sullivan. Together, they contribute to the ongoing research and development of groundbreaking diagnostic methods.

Conclusion

Mark Dalphin's contributions to bladder cancer detection and treatment exemplify the impact of innovation in healthcare. His patents reflect a commitment to improving diagnostic accuracy and patient care, making him a significant figure in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…